Clinical trial
Phase II/III Study of Oral Prednisolone Test in Patients With Rheumatoid Arthritis
NCT01395251 is registered in ClinicalTrials.gov with Rheumazentrum Ruhrgebiet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II/III Study of Oral Prednisolone Test in Patients With Rheumatoid Arthritis
- Lead sponsor
- Rheumazentrum Ruhrgebiet
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- December 31, 2014
- Enrollment
- 130 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis